Skip to Content

    News and Insights

    EQT Holdings Limited (ASX: EQT), the holding company for Equity Trustees, today announced it has appointed non executive director James (Jim) Minto as Deputy Chair of the Board.
    EQT Holdings Limited (ASX: EQT), the holding company for Equity Trustees, today announced it has appointed non executive director James (Jim) Minto as Deputy Chair of the Board.
    2019 Half Year Results Presentation

    Take a look at our 2019 Half Year Results Presentation

    Australia’s leading specialist trustee company Equity Trustees has appointed Sue Everingham as a director to the Board of Equity Trustees Superannuation Limited (ETSL).

    Listen to the webinar presentation by Mick O’Brien, Managing Director and Philip Gentry, Chief Financial Officer  & Chief Operating Officer speaking about EQT’s Half Year Results. 25 February 2019

    EQT Holdings Limited (ASX: EQT), the holding company for Equity Trustees, today announced it had signed an agreement with Zurich Australia to purchase its superannuation trustee, Zurich Australian Superannuation Pty Limited (ZAS).

    EQT Holdings Limited (ASX: EQT), the holding company for Equity Trustees, today announced it had signed an agreement with Zurich Australia to purchase its superannuation trustee, Zurich Australian Superannuation Pty Limited (ZAS).

    Working at Wintringham Annie Wakeford
    Annie Wakeford is a Tenancy Management Worker at Wintingham. Helping resilient people find a place to call home.
    Palliative care and dementia - rethinking how we do it
    The beginning of the Royal Commission into Aged Care Quality and Safety is a timely reminder to focus on what makes quality aged care
    Australia’s leading specialist trustee company Equity Trustees has appointed a new senior client management professional to its expanding national Superannuation Trustee Office.
    Bridging the gender equality gap in medicine and science
    In mid-2014, Joseph Sambrook and Mary-Jane Gething – both now retired after distinguished careers in the fields of biochemistry and molecular biology – established a private ancillary fund (PAF) managed by Equity Trustees.